hemodialysis. Encounter for adequacy testing for hemodialysis
Conditions
Interventions
Intervention 1: Control group: In this group, patients will receive a placebo vial similar to the L-carnitine vial daily for 16 weeks. Intervention 2: Intervention group: In this group, all patients w
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Hemodialysis patients referred to Hami Dialysis Center in Arak city, who undergo dialysis three times a week for at least three months. Body mass index in the range of 18.5-35
Exclusion criteria
Exclusion criteria: Having thyroid disorders (hyper and hypothyroid) The presence of nervous and mental illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction ratio of urea. Timepoint: Before the intervention, the 8th week of the study and after the intervention. Method of measurement: Formula: blood urea after dialysis - blood urea before dialysis) / blood urea before dialysis.;Urea Kinetic Modeling. Timepoint: Before the intervention, the 8th week of the study and after the intervention. Method of measurement: The volume of purified plasma divided by the volume of urea distribution.;Hemoglobin. Timepoint: Before the intervention, the 8th week of the study and after the intervention. Method of measurement: complete blood count.;Appetite status. Timepoint: Before the intervention, the 8th week of the study and after the intervention. Method of measurement: Ask the patient.;Consumption of food groups. Timepoint: Before the intervention, the 8th week of the study and after the intervention. Method of measurement: Food frequency questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Farshid Haghverdi
Arak University of Medical Sciences
Outcome results
None listed